Nasdaq
EssilorLuxottica: Disclosure of transactions in own shares
22-04-2025
Disclosure of transactions in own shares
Paris, France (April 22, 2025 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders’ Meeting on April 30, 2024, EssilorLuxottica declares that from April 15, 2025, to April 17, 2025, inclusive, the following share buybacks were carried out:
| Name of the issuer | Identity code of the Issuer | Day of the transaction | Identity code of the financial instrument |
Total daily volume (in number of shares) |
Daily weighted average purchase price of the shares (€) * |
Market (MIC Code) |
| ESSILORLUXOTTICA | 549300M3VH1A3ER1TB49 | 15/04/2025 | FR0000121667 | 24,785 | 249.5423 | XPAR |
| ESSILORLUXOTTICA | 549300M3VH1A3ER1TB49 | 15/04/2025 | FR0000121667 | 18,734 | 249.7055 | CEUX |
| ESSILORLUXOTTICA | 549300M3VH1A3ER1TB49 | 16/04/2025 | FR0000121667 | 81,951 | 248.8297 | XPAR |
| ESSILORLUXOTTICA | 549300M3VH1A3ER1TB49 | 16/04/2025 | FR0000121667 | 18,049 | 248.5505 | CEUX |
| ESSILORLUXOTTICA | 549300M3VH1A3ER1TB49 | 17/04/2025 | FR0000121667 | 60,000 | 248.0219 | XPAR |
| ESSILORLUXOTTICA | 549300M3VH1A3ER1TB49 | 17/04/2025 | FR0000121667 | 40,000 | 247.9342 | CEUX |
| TOTAL | 243,519 | 248.6028 | ||||
* Rounded to four decimal places
Attachment

Latest Health & Supplement Reviews
- YuSleep Reviews (EXPOSED) Doctor Explains Deep Sleep Benefits, Hidden Risks & Real Consumers Results In 2026
- Neuro Energizer Reviews and Complaints 2026: How This Neuro-Sonic Breakthrough Is Reshaping Cognitive Therapy, Memory & Daily Focus
- Gluco6 Reviews and Complaints (March 2026) Real User Data on Natural Blood Sugar Balance and Glucose Stability